Press Releases

2024

May 15, 2024
Parnell Introduces Two New Sedation Products to Pet Care Product Line

Mar 7, 2024
Parnell Welcomes Dr. Chelsie Estey as Vice President of U.S. Pet Care

2023

Nov 6, 2023
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum

May 31, 2023
Parnell Adds Three Experts to Leadership Team

May 31, 2023
Two New Territory Business Managers Help Parnell Better Serve Producers and Veterinarians

Mar 7, 2023
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum

Jan 25, 2023
Parnell Living Science Introduces BRD Solution RESPIRmycin™

Jan 6, 2023
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering

2022

Dec 6, 2022
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering

Dec 1, 2022
Parnell Pharmaceuticals Holdings Ltd Announces Proposed Rights Offering

Jun 21, 2022
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum

2021

Jul 14, 2021
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum

Feb 1, 2021
DW Healthcare Partners Invests in Parnell

Jan 29, 2021
DWHP Announces Expiration And Final Results Of Its Cash Tender Offer For All Outstanding Ordinary Shares Of Parnell Pharmaceuticals Holdings Ltd

Jan 22, 2021
Parnell Announces Notice of 2020 Annual General Meeting and Explanatory Memorandum

Jan 21, 2021
DWHP Announces Extension of The Expiration Time of Its Tender Offer

2020

Dec 21, 2020
DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd

Dec 21, 2020
Results of Annual General Meeting of Shareholders Held December 17, 2020

2019

Dec 23, 2019
Parnell Pharmaceuticals Holdings Ltd Announces Business Update

Oct 14, 2019
Parnell Pharmaceuticals Holdings Ltd Announces New CDMO Agreement and Business Update

Jun 7, 2019
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Quarter Ended 31 March 2019

Apr 30, 2019
Notice of Annual General Meeting and Explanatory Memorandum

Apr 5, 2019
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Year Ended 31 December 2018 and 2019 Guidance

2018

Nov 2, 2018
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018

Aug 3, 2018
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended 30 June 2018

Jul 31, 2018
Parnell Pharmaceuticals Holdings Completes Debt Refinancing With Marathon Asset Management

Jun 5, 2018
Results of Annual General Meeting of Shareholders Held May 31, 2018

Apr 30, 2018
Notice of Annual General Meeting and Explanatory Memorandum

Apr 27, 2018
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended March 31, 2018 and Reports 2017 Full Year Financial Results

Feb 22, 2018
Results of General Meeting of Shareholders Held February 22, 2018

Jan 11, 2018
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Nine Months Ended September 30, 2017; Board and Senior Management Changes; Strategic Review of Development Pipeline Including Zydax Canine and 2018 Guidance

Jan 11, 2018
Notice of General Meeting and Explanatory Memorandum

Jan 4, 2018
Parnell Appoints Tony G Hartnell AM to Board of Directors

Jan 3, 2018
Results of General Meeting of Shareholders held December 29, 2017

2017

Nov 21, 2017
Notice of Annual General Meeting and Explanatory Memorandum

Aug 17, 2017
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017

May 24, 2017
Parnell Pharmaceuticals Holdings Ltd Announces Business Results Update

May 18, 2017
Parnell to Report Business Update for the Three Months Ended March 31, 2017 on May 24, 2017

Apr 28, 2017
Notice of Annual General Meeting and Explanatory Memorandum

Mar 21, 2017
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2016

Feb 27, 2017
UPDATED: Parnell to Report Financial Results for Fiscal Year 2016 on March 21, 2017 

Feb 23, 2017
Parnell to Report Financial Results for Fiscal Year 2016 on March 22, 2017

2016

Dec 19, 2016
Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

Dec 9, 2016
Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the OTC Pink® Open Market

Nov 22, 2016
Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility

Nov 2, 2016
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016

Oct 27, 2016
Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016

Aug 4, 2016
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016

Jul 26, 2016
Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

May 31, 2016
Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial

May 12, 2016
Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock

Apr 22, 2016
Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update

Apr 18, 2016
Parnell to Report Business Results for the Three Months Ended March 31, 2016 on April 22, 2016

Mar 31, 2016
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies Animal Health Summit

Feb 24, 2016
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2015

Feb 18, 2016
Parnell to Report Financial Results for Fiscal Year 2015 on February 24, 2016

Jan 20, 2016
UPDATE — Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Capital Fund to Purchase Ordinary Shares

Jan 19, 2016
Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Capital Fund to Purchase Ordinary Shares

Jan 11, 2016
Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference in San Francisco

2015

Dec 17, 2015
Parnell Appoints Ellen B. Richstone and Dr. David K. Rosen to the Board of Directors

Nov 18, 2015
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Global Healthcare Conference in London

Oct 21, 2015
Parnell Pharmaceuticals Holdings Ltd Announces Third Quarter Business Results

Oct 9, 2015
Parnell to Report Financial Results for the Nine Months Ended September 30, 2015 on October 21, 2015

Oct 9, 2015
Parnell Pharmaceuticals Holdings Ltd Restructures Board

Sep 28, 2015
Parnell Pharmaceuticals Holdings Ltd to Present at Ladenburg Thalmann 2015 Healthcare Conference

Aug 11, 2015
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2015

Aug 10, 2015
Parnell Appoints Peter A. Croden to Board of Directors

Jul 29, 2015
Parnell to Report Financial Results for the Six Months Ended June 30, 2015 on August 11, 2015

Jun 18, 2015
Parnell Pharmaceuticals Holdings Ltd Investor Day Highlights

Jun 18, 2015
Parnell Pharmaceuticals Holdings Ltd Announces $11 Million Secured Term Loan Facility

Jun 18, 2015
Parnell Pharmaceuticals Holdings Ltd Announces Positive Top-Line Pivotal Trial Results for Zydax(R), Disease-Modifying Osteoarthritis Drug in Dogs

Jun 8, 2015
Parnell Pharmaceuticals Holdings Ltd to Participate in Two Upcoming Investor Conferences

May 20, 2015
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Healthcare Conference

Apr 22, 2015
Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Results

Apr 13, 2015
Parnell to Discuss First Quarter Business Performance on April 22, 2015

Mar 9, 2015
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Animal Health Summit

Feb 25, 2015
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended December 31, 2014

Jan 12, 2015
Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference

2014

Dec 19, 2014
Parnell Management Adopts 10b5-1 Trading Plans

Dec 9, 2014
Parnell Announces Key Senior Management and Director Appointments

Dec 9, 2014
Parnell Pharmaceuticals Holdings Ltd Announces Change in Fiscal Year-End

Nov 12, 2014
Parnell Pharmaceuticals Holdings Ltd to Present at Upcoming Investor Conferences

Sep 15, 2014
Parnell Pharmaceuticals Holdings Ltd Announces Fiscal Year 2014 Financial Results

Sep 10, 2014
Parnell to Report Fiscal Year 2014 Financial Results September 15, 2014

Sep 8, 2014
Parnell Appoints US-Based Independent Directors Phyllis Gardner, M.D., and David L. Greenwood to Its Board of Directors

Sep 3, 2014
Parnell Announces Results From the Successful Efficacy Study for Zydax(R)

Jul 24, 2014
Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration

Jun 18, 2014
Parnell Pharmaceuticals (NASDAQ: PARN) to Ring The NASDAQ Stock Market Opening Bell in Celebration of IPO

May 21, 2014
Parnell Pharmaceuticals Files Registration for Proposed Initial Public Offering

2013

Feb 25, 2013
Parnell Launches Synchronization Pack™

2009

Aug 1, 2009
Australian Veterinary Pharmaceuticals Company Opens World Class Manufacturing Facility